Claros, S.; Cabrera, P.; Valverde, N.; Romero-Zerbo, S.Y.; López-González, M.V.; Shumilov, K.; Rivera, A.; Pavia, J.; MartÃn-Montañez, E.; Garcia-Fernandez, M.
Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants 2022, 11, 41.
https://doi.org/10.3390/antiox11010041
AMA Style
Claros S, Cabrera P, Valverde N, Romero-Zerbo SY, López-González MV, Shumilov K, Rivera A, Pavia J, MartÃn-Montañez E, Garcia-Fernandez M.
Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants. 2022; 11(1):41.
https://doi.org/10.3390/antiox11010041
Chicago/Turabian Style
Claros, Silvia, Pablo Cabrera, Nadia Valverde, Silvana Y. Romero-Zerbo, Manuel VÃctor López-González, Kirill Shumilov, Alicia Rivera, Jose Pavia, Elisa MartÃn-Montañez, and MarÃa Garcia-Fernandez.
2022. "Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons" Antioxidants 11, no. 1: 41.
https://doi.org/10.3390/antiox11010041
APA Style
Claros, S., Cabrera, P., Valverde, N., Romero-Zerbo, S. Y., López-González, M. V., Shumilov, K., Rivera, A., Pavia, J., MartÃn-Montañez, E., & Garcia-Fernandez, M.
(2022). Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons. Antioxidants, 11(1), 41.
https://doi.org/10.3390/antiox11010041